Marianowski L, Grzechocińska B
I Katedry i Kliniki Połoznictwa i Ginekologii AM w Warszawie.
Ginekol Pol. 1995 May;66(5):294-6.
Clinical results of a new contraceptive pills--Marvelon (Organon) were studied. 32 women, ages 30 +/- 5 years, participated in the study during at least 6 cycles. Marvelon was good tolerated and subjective side-effects were very low. The cycles were regular, duration of withdrawal bleeding was 3-5 days and the amount of the blood lost were unchanged or milder. Marvelon didn't affect body weight and blood pressure. Favourable lipid profile--increased a mean level of HDL-Cholesterol and decreased a mean level of LDL-Cholesterol were noticed. Pearl Index was 0,0.
对一种新型避孕药——妈富隆（欧加农公司生产）的临床效果进行了研究。32名年龄在30±5岁的女性参与了至少6个周期的研究。妈富隆耐受性良好，主观副作用非常低。月经周期规律，撤退性出血持续时间为3 - 5天，失血量未变或减少。妈富隆不影响体重和血压。观察到有利的血脂状况——高密度脂蛋白胆固醇平均水平升高，低密度脂蛋白胆固醇平均水平降低。Pearl指数为0.0。
